Free Trial

VYNE Therapeutics (VYNE) SEC Filings & 10K Form

VYNE Therapeutics logo
$2.42 -0.22 (-8.33%)
(As of 12/18/2024 05:44 PM ET)

Recent VYNE Therapeutics SEC Filings

DateFilerForm TypeView
12/13/2024
3:15 PM
Bruno Anthony D (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
Sandoval Elisabeth (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
BARBARI SHARON (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
Basta Steven L (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
LEPORE PATRICK G (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:15 PM
Borowski Christine (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
7:03 AM
VYNE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
7:01 AM
VYNE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:04 AM
VYNE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
3:30 PM
Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
7:00 AM
VYNE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
4:02 PM
Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:04 PM
Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
11:15 PM
VYNE Therapeutics (Filer)
Form EFFECT
03/01/2024
4:15 PM
VYNE Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/01/2024
4:16 PM
VYNE Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/29/2024
7:12 AM
VYNE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
VYNE Therapeutics (Subject)
Form SC 13G/A
02/02/2024
8:42 AM
Soleus Capital Master Fund, L.P. (Filed by)
VYNE Therapeutics (Subject)
Form SC 13G/A
01/03/2024
4:17 PM
Domzalski David (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:20 PM
Harsch Mutya (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:21 PM
Stuart Iain (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:22 PM
VYNE Therapeutics (Issuer)
Zeronda Tyler (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:07 PM
Borowski Christine (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:09 PM
BARBARI SHARON (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:10 PM
Basta Steven L (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:11 PM
Bruno Anthony D (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:13 PM
LEPORE PATRICK G (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
4:14 PM
Sandoval Elisabeth (Reporting)
VYNE Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
7:15 AM
VYNE Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VYNE) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners